The impact of an amputation is more than losing a limb. From loss of mobility and independence to struggles with mental health, patients face a new reality. Pain shouldn't add to that burden.

See how the cryoXT™ probe offers a proactive solution to post-amputation pain:

The impact of an amputation goes far beyond just losing a limb.
From changes in mobility and independence to challenges with mental and emotional health, amputation patients face a new reality after surgery.

Pain shouldn't add to that burden. With the cryoXT™ probe, surgeons can offer a proactive, non-opioid option to post-amputation pain management

Learn more: <a href="https://okt.to/09TUVf&quot; target="_blank">https://okt.to/09TUVf</a&gt;

<a href='https://www.linkedin.com/feed/hashtag/?keywords=PainManagement&highligh…; target='_blank'>#PainManagement</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=Amputation&highlightedU…; target='_blank'>#Amputation</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=VascSurg&highlightedUpd…; target='_blank'>#VascSurg</a>

For patients with Advanced Afib, endocardial ablation alone may not be enough.

Dr. Na shares why he chooses Hybrid AF™ Therapy and how a collaborative epicardial and endocardial approach can provide another option for appropriate patients.

Learn more about a Hybrid approach:

Long-standing persistent Afib (Advanced Afib) is a serious disease that deserves a comprehensive treatment approach.

For patients with Advanced Afib, endocardial ablation alone may not be enough.

Dr. Na shares why he chooses Hybrid AF™ Therapy and how a collaborative epicardial and endocardial approach can provide another option for appropriate patients.

<a href='https://www.linkedin.com/feed/hashtag/?keywords=AfibAwarenessMonth&high…; target='_blank'>#AfibAwarenessMonth</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=HybridAFTherapy&highlig…; target='_blank'>#HybridAFTherapy</a>

What do two-year outcomes look like after concomitant epicardial surgical ablation during CABG?

A multicenter analysis of 537 patients from the TRAC-AF Registry found:​​
- 94% and 89% survival at 12 and 24 months, respectively​.
- 85% and 77% freedom from atrial arrhythmias at

Read more about the findings here:

What do two-year outcomes look like after concomitant epicardial surgical ablation during CABG?

A multicenter analysis of 537 patients from the TRAC-AF Registry found:​​
- 94% and 89% survival at 12 and 24 months, respectively​.
- 85% and 77% freedom from atrial arrhythmias at 12 and 24 months, respectively.​

Read more about the findings here: <a href="https://okt.to/QKExLU&quot; target="_blank">https://okt.to/QKExLU</a&gt;

Robust. Transmural. Contiguous.

That's what a successful ablation requires and what the Isolator® Synergy™ EnCompass® clamp was built to deliver.

<a href="https://twitter.com/hashtag/CardioTwitter?src=hashtag_click&quot; target="_blank">#CardioTwitter</a> <a href="https://twitter.com/hashtag/SurgicalAblation?src=hashtag_click&quot; target="_blank">#SurgicalAblation</a>

The EnCompass clamp utilizes Synergy technology to provide real-time, adaptive energy delivery – precisely to the specific tissue between the jaws.

The result: discrete, reproducible lesions that stand the test of time. Learn more:

Robust. Transmural. Contiguous.

That's what a successful ablation requires and what the Isolator® Synergy™ EnCompass® clamp was built to deliver.

The EnCompass clamp utilizes Synergy technology to provide real-time, adaptive energy delivery – precisely to the specific tissue between the jaws.

The result: discrete, reproducible lesions that stand the test of time.

<a href='https://www.linkedin.com/feed/hashtag/?keywords=SurgicalAblation&highli…; target='_blank'>#SurgicalAblation</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=CardiacSurgery&highligh…; target='_blank'>#CardiacSurgery</a>